Diffuse Midline Glioma Clinical Trials

13 clinical trials for Diffuse Midline Glioma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). — RECRUITING · PHASE2
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors — RECRUITING · PHASE1
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors — RECRUITING · PHASE1
International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository — RECRUITING
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma — RECRUITING · PHASE1
GD2-CAR T Cells for Pediatric Brain Tumours — RECRUITING · PHASE1
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma — SUSPENDED · PHASE1
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) — NOT_YET_RECRUITING · PHASE1
Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor — NOT_YET_RECRUITING · PHASE1
Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors — ACTIVE_NOT_RECRUITING · PHASE1
Oral ONC201 in Adult Recurrent Glioblastoma — TERMINATED · PHASE2
A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG — SUSPENDED · PHASE2
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas — COMPLETED · PHASE1

Refine this search